Cipla

Cipla Limited
Trade name	Cipla
Formerly	Chemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984)
Company type	Public
Traded as	BSE: 500087; NSE: CIPLA; NSE NIFTY 50 constituent
ISIN	INE059A01026
Industry	Pharmaceuticals
Founded	1935
Founder	Khwaja Abdul Hamied
Headquarters	Mumbai, Maharashtra, India
Area served	Worldwide
Key people	Y. K. Hamied (Chairperson); Umang Vohra (CEO);
Products	Pharmaceutical drugs; generic drugs; antiviral drugs; over-the-counter drugs; vaccines; diagnostics; contact lenses; animal health; dietary supplements; protein supplements;
Revenue	₹25,455 crore (US$3.0 billion) (FY24)
Operating income	₹6,233 crore (US$750 million) (FY24)
Net income	₹4,106 crore (US$490 million) (FY24)
Total assets	₹32,511 crore (US$3.9 billion) (FY24)
Total equity	₹26,706 crore (US$3.2 billion) (FY24)
Number of employees	22,036
Subsidiaries	Invagen Pharmaceuticals
Website	www.cipla.com

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.^[3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.^[4]^[5]

^ ^a ^b ^c ^d ^e "Q4 FY24 Investor Presentation" (PDF). Cipla. Retrieved 19 May 2024.
^ "Business Responsibility Report 2013-14" (PDF). Cipla. 15 July 2014. Archived from the original (PDF) on 17 March 2015. Retrieved 17 September 2014.
^ "Know 10 largest Pharmaceutical Companies in India". Edu Dwar. Retrieved 28 July 2023.
^ "Cipla betting big on digitisation and emerging segments". The Economic Times. Retrieved 6 December 2022.
^ "Cipla betting big on digitisation and emerging segments". Financial Express. Retrieved 6 December 2022.